
Shiseido Company reported H1 2025 net sales of JPY469.8 billion, a 6% year-over-year decline, primarily due to weakness in China Travel Retail and the underperformance of Drunk Elephant. Despite sales headwinds, core operating profit surged JPY4.1 billion to JPY23.4 billion, significantly exceeding expectations and achieving over 60% of the full-year JPY36.5 billion guidance, driven by successful structural reforms and rigorous cost management across Japan, China, and Travel Retail. While the full-year net sales outlook is now anticipated to be flattish, the company is accelerating cost reduction targets to JPY25 billion for 2025 and JPY50 billion for 2025-2026, with significant restructuring underway in the underperforming Americas business, which faces increased impairment risk due to Drunk Elephant's continued struggles.
Shiseido's H1 2025 results demonstrate a successful execution of operational discipline amidst significant top-line pressure. Despite a 6% underlying decline in net sales to JPY469.8 billion, core operating profit rose by JPY4.1 billion year-over-year to JPY23.4 billion, substantially outperforming expectations. This divergence was driven by aggressive structural reforms and cost management, which delivered JPY13.5 billion in cost reductions in H1, primarily from personnel expense cuts in Japan, China, and Travel Retail. Regional performance highlights this trend: Japan's profit increased significantly despite a revenue decrease, and the China/Travel Retail segment maintained a high 22.1% profit margin. However, the Americas business remains a critical point of weakness, with its operating profit dropping JPY3.3 billion due to the severe underperformance of the Drunk Elephant brand, which the company admits has lost its competitive edge and customer base. Consequently, management has explicitly flagged that the risk of a material impairment loss on the Americas business is "greater than ever." While the full-year core operating profit forecast of JPY36.5 billion is maintained, the company now anticipates flattish sales growth, signaling that future performance relies heavily on achieving an increased cost reduction target of JPY25 billion for the year.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment